Curis Inc (CRIS) Stock Price, Quote & News

Company Profile

Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small-molecule IRAK4 kinase inhibitor, which is in a Phase 1/2 open-label, single-arm expansion trial in patients with relapsed or refractory, or R/R, AML and high-risk myelodysplastic syndromes. The company's pipeline also includes Fimepinostat, an oral dual inhibitor of HDAC and...

Industry: Biotechnology

Sector: Healthcare

Phone: 617 503 6500

Website: www.curis.com

Address:

Building C, Suite 500 128 Spring Street, Lexington, United States

jeremy50641 Nov. 15 at 8:02 PM

$CRIS is this going to get delisted or did they get a extension?

0 · Reply

TCzeck Nov. 15 at 1:18 AM

$CRIS Next week this will run hard! More likely well over $2 per share. 🤙🏻 Every stock I see run several dollars has news like this. Can't wait!

1 · Reply

Yodalay Nov. 14 at 12:05 AM

$CRIS completed the sale of its Erivedge Business to TPC Investments Royalty LLC, releasing liabilities related to future royalties. This transaction will result in a gain for Curis in the fourth quarter of 2025 and extinguish its royalty-related liabilities. This clears any liabilities that may be preventing a sale of large investment, good move, overdue. Seems to be overlooked, but IMHO it is setting up for partner, sale, or large investment. A lot of fear right now, with extension approaching. I dont see a de-list, to much happening in the next 3 months. IMHO, do your own DD

2 · Reply

Yodalay Nov. 13 at 11:59 PM

$CRIS $CRIS Generational Low. - Three presentations at SNO on November 19-23: - Initial clinical data from the ongoing frontline AML triplet study at ASH in December 6-9 - P1 Pancreatic Cancer results on January 08 for Emavusertib - Initial clinical data from a Study (IST) in pancreatic ductal adenocarcinoma (PDAC) will be reported at the ASCO Gastrointestinal Cancers Symposium on January 8-10, 2026

0 · Reply

GenralZod Nov. 13 at 5:36 PM

$CRIS I agree with stevemero

0 · Reply

LodiDodiWeLikesToParty Nov. 12 at 9:43 PM

$CRIS 16k to $250

3 · Reply

DJHILL96 Nov. 12 at 8:56 PM

$CRIS this is so depressing. My investment has gone from 22k to only 2k. How much have you guys lost with this stock??

1 · Reply

ChaseDeluca Nov. 12 at 1:48 AM

Watch AMZE could head over .75 and towards $1+ if volume is consistent, todays news was overlooked and this thing is so beaten down, the b.ounce could be ferocious in itself, + the news now. $BLMZ $IOR $CRIS $SSII

0 · Reply

Topzero Nov. 11 at 2:52 PM

$CRIS I have told you 1000 times that you must get out of this ugly Arrow and you are adamant that you don't want to get out , like monkeys jumping from tree to tree, about what you lose and it turns into OTC don't cry, darling, because if I see you cry I will put my finger in your stinking ass

0 · Reply

Love_To_Learn Nov. 10 at 6:02 PM

$CRIS $HIND REQUIRE YOUR SERVICES SOON ISH

0 · Reply

Curis to Present at Upcoming 30th Annual SNO Meeting

Nov 7, 2025, 1:56 PM EST - 9 days ago

Curis, Inc. (CRIS) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 4:00 PM EST - 10 days ago

Curis Provides Third Quarter 2025 Business Update

Oct 30, 2025, 4:00 PM EDT - 17 days ago

Curis to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on November 6, 2025

Oct 3, 2025, 4:00 PM EDT - 6 weeks ago

Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Sep 12, 2025, 9:45 AM EDT - 2 months ago

Curis, Inc. (CRIS) Presents At Cantor Global Healthcare Conference 2025 Transcript

Sep 11, 2025, 5:20 AM EDT - 2 months ago

Curis, Inc. (CRIS) Presents At H.C. Wainwright 27th Annual Global Investment Conference Transcript

Sep 2, 2025, 10:43 AM EDT - 2 months ago

Curis to Present at Upcoming Healthcare Conferences in September

Aug 5, 2025, 11:25 AM EDT - 3 months ago

Curis, Inc. (CRIS) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 8:00 AM EDT - 3 months ago

Curis Provides Second Quarter 2025 Business Update

Jul 29, 2025, 8:30 AM EDT - 3 months ago

Curis to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on August 5, 2025

Jul 2, 2025, 8:32 AM EDT - 4 months ago

Curis Announces $7.0 Million Registered Direct and Concurrent Private Placement

May 6, 2025, 2:40 PM EDT - 6 months ago

Curis, Inc. (CRIS) Q1 2025 Earnings Call Transcript

May 6, 2025, 8:00 AM EDT - 6 months ago

Curis Provides First Quarter 2025 Business Update

Apr 29, 2025, 8:00 AM EDT - 7 months ago

Curis to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on May 6, 2025

Apr 2, 2025, 4:05 PM EDT - 8 months ago

Curis to Present at Upcoming Healthcare Conference in April

Mar 31, 2025, 9:59 AM EDT - 8 months ago

Curis, Inc. (CRIS) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 8:00 AM EDT - 8 months ago

Curis Provides Fourth Quarter 2024 Business Update

Mar 28, 2025, 4:07 PM EDT - 8 months ago

Curis to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on March 31, 2025

Dec 10, 2024, 8:00 AM EST - 1 year ago

Curis Announces Additional Data from TakeAim Leukemia Study

Nov 14, 2024, 11:02 AM EST - 1 year ago

Curis, Inc. (CRIS) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 8:00 AM EST - 1 year ago

Curis Provides Third Quarter 2024 Business Update

Nov 7, 2024, 8:00 AM EST - 1 year ago

Curis to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on November 14, 2024

Oct 29, 2024, 6:04 AM EDT - 1 year ago

Curis Announces $12.1 Million Registered Direct and Concurrent Private Placement

Sep 23, 2024, 8:30 AM EDT - 1 year ago

Curis Announces the 3rd Annual Symposium on IRAK4 in Cancer

Sep 17, 2024, 7:30 AM EDT - 1 year ago

Curis to Participate at the Upcoming 2024 Cantor Fitzgerald Global Healthcare Conference

Aug 1, 2024, 3:44 PM EDT - 1 year ago

Curis, Inc. (CRIS) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 8:00 AM EDT - 1 year ago

Curis Provides Second Quarter 2024 Financial and Operating Update

Jul 25, 2024, 8:00 AM EDT - 1 year ago

Curis to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024

Jul 10, 2024, 7:30 AM EDT - 1 year ago

Curis to Present at Upcoming Healthcare Conference in July

May 10, 2024, 8:00 AM EDT - 1 year ago

Curis to Present Updated Data from the TakeAim Leukemia Study

May 7, 2024, 8:08 PM EDT - 1 year ago

Curis, Inc. (CRIS) Q1 2024 Earnings Call Transcript

May 7, 2024, 8:00 AM EDT - 1 year ago

Curis Provides First Quarter 2024 Business Update

Apr 30, 2024, 8:00 AM EDT - 1 year ago

Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024

Apr 4, 2024, 7:30 AM EDT - 1 year ago

Curis to Present at Upcoming Healthcare Conferences in April

Feb 8, 2024, 2:04 PM EST - 1 year ago

Curis, Inc. (CRIS) Q4 2023 Earnings Call Transcript

Feb 8, 2024, 8:00 AM EST - 1 year ago

Curis Provides Fourth Quarter 2023 Business Update

Feb 1, 2024, 8:00 AM EST - 1 year ago

Curis to Release Fourth Quarter 2023 Financial Results and Hold Conference Call on February 8, 2024

Dec 12, 2023, 8:00 AM EST - 2 years ago

Curis Announces Initial Combination Study Data from its TakeAim Lymphoma Study

Dec 11, 2023, 8:00 AM EST - 2 years ago

Curis Presented Clinical Data from the TakeAim Leukemia Study at the 2023 ASH Conference

Dec 6, 2023, 8:00 AM EST - 2 years ago

Curis Announces Three Presentations at ASH

Dec 5, 2023, 8:00 AM EST - 2 years ago

Curis Enters into Agreement for Emavusertib / Pembrolizumab Combination Study in Melanoma

Nov 17, 2023, 9:04 AM EST - 2 years ago

Curis's stock rises as analysts see ‘the next Pharmacyclics'

Nov 2, 2023, 2:32 PM EDT - 2 years ago

Curis, Inc. (CRIS) Q3 2023 Earnings Call Transcript

Nov 2, 2023, 8:00 AM EDT - 2 years ago

Curis Provides Third Quarter 2023 Business Update

Oct 26, 2023, 8:30 AM EDT - 2 years ago

Curis to Release Third Quarter 2023 Financial Results and Hold Conference Call on November 2, 2023

Sep 12, 2023, 8:00 AM EDT - 2 years ago

Curis Announces Date for the 2nd Symposium on IRAK4 in Cancer

Aug 3, 2023, 9:35 PM EDT - 2 years ago

Curis, Inc. (CRIS) Q2 2023 Earnings Call Transcript

Aug 3, 2023, 4:01 PM EDT - 2 years ago

Curis Provides Second Quarter 2023 Business Update

jeremy50641 Nov. 15 at 8:02 PM

$CRIS is this going to get delisted or did they get a extension?

0 · Reply

TCzeck Nov. 15 at 1:18 AM

$CRIS Next week this will run hard! More likely well over $2 per share. 🤙🏻 Every stock I see run several dollars has news like this. Can't wait!

1 · Reply

Yodalay Nov. 14 at 12:05 AM

2 · Reply

Yodalay Nov. 13 at 11:59 PM

0 · Reply

GenralZod Nov. 13 at 5:36 PM

$CRIS I agree with stevemero

0 · Reply

LodiDodiWeLikesToParty Nov. 12 at 9:43 PM

$CRIS 16k to $250

3 · Reply

DJHILL96 Nov. 12 at 8:56 PM

$CRIS this is so depressing. My investment has gone from 22k to only 2k. How much have you guys lost with this stock??

1 · Reply

ChaseDeluca Nov. 12 at 1:48 AM

0 · Reply

Topzero Nov. 11 at 2:52 PM

0 · Reply

Love_To_Learn Nov. 10 at 6:02 PM

$CRIS $HIND REQUIRE YOUR SERVICES SOON ISH

0 · Reply

BallWasher69 Nov. 10 at 3:16 PM

$CRIS 11/14 is this Friday….lets see what happens….🙏🏻

0 · Reply

paarthshah356 Nov. 10 at 1:50 PM

Latest gmp Curis life 6% Shinning tools 2% Pine labs negative to flat Grow 3-4% $CRIS

0 · Reply

Topzero Nov. 7 at 2:50 PM

$CRIS Don’t believe the pigs! They’re selling way more than they’re buying. Be very careful – you’ll regret it if you buy! They’ll crash the price down to 0.4 cents. But if you DON’T buy, they have no choice but to pump the stock up. Every time they pump it, sell a portion of what you own immediately. This is a company that will be delisted from the market soon. Caution is a must!

0 · Reply

Topzero Nov. 7 at 2:49 PM

0 · Reply

Topzero Nov. 7 at 2:36 PM

$CRIS 🐶🐶🐶 ‏ Big drop 🤣

0 · Reply

d_risk Nov. 7 at 12:09 AM

$CRIS - CURIS INC - 10Q - Updated Risk Factors CRIS flags heightened risks from US-China trade tensions and tariffs impacting supply chains and costs, plus expanded concerns over FDA delays from workforce cuts, shutdowns, and regulatory reforms affecting drug approvals and development. #Biotechnology #RegulatoryRisk #FDADelays #SupplyChainRisk #USChinaTrade 🟢 Added 🟠 Removed https://d-risk.ai/CRIS/10-Q/2025-11-06

0 · Reply

RedDrumification Nov. 6 at 9:56 PM

$CRIS wow, a handful of analysts' questions and not one on where's the moneys to stay open is coming from and not a peep about delisting. Guess it's just rainbows and sunshine in DentzerWorld!

1 · Reply

steveMero Nov. 6 at 7:38 PM

$CRIS bankruptcy?

0 · Reply

GenralZod Nov. 6 at 6:21 PM

$CRIS can they get another extension on delisting? only way to surpass $35M cap is a big partner which will only occur from tremendous data. no?

0 · Reply

WillyBagman Nov. 6 at 4:07 PM

$CRIS Earnings today after close!

0 · Reply

UCD_12dd Nov. 5 at 7:53 PM

$CRIS slip slidin away…

0 · Reply

SqueezeChronometer Nov. 2 at 12:06 PM

Next major retail squeeze candidate right here $CRIS $PEBO $GERN $MRCY

0 · Reply

Market Cap	17.20M
Revenue (ttm)	10.91M
Net Income (ttm)	-43.39M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-397.71%
Debt to Equity Ratio	0.00

Volume	130,000
Avg Vol	73,458
Day's Range	N/A - N/A
Shares Out	12.93M
Stochastic %K	55%
Beta	3.88
Analysts	Strong Sell
Price Target	$14.50